Agtc stock zacks
22/12/2015 · Applied Genetic Technologies CorporationAGTC was a big mover last session, as the company saw its shares rise over 8% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading 20/11/2019 · Zacks Investment Research upgraded shares of Applied Genetic Technologies (NASDAQ:AGTC) from a sell rating to a hold rating in a report issued on Tuesday morning, Zacks.com reports. According to Zacks, “Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for 07/05/2015 · Applied Genetic Technologies Corporation ( AGTC) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The upside came after researchers from Michigan State University and the University of Pennsylvania presented … Zacks Investment Research cut shares of Applied Genetic Technologies (NASDAQ:AGTC) from a buy rating to a hold rating in a research report report published on Monday, Zacks.com reports. According to Zacks, “Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited
1 day ago Shares of Applied Genetic Technologies Corp (NASDAQ:AGTC) have been One equities research analyst has rated the stock with a sell rating, one the quarter, missing the Zacks' consensus estimate of ($0.58) by ($0.06).
20/11/2019 · Zacks Investment Research upgraded shares of Applied Genetic Technologies (NASDAQ:AGTC) from a sell rating to a hold rating in a research note issued to investors on Tuesday morning, Zacks.com reports. According to Zacks, “Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy Looking for stock market Thank you for your interesting in enabling additional Zacks content & features within Zacks advisor Tools. Clicking OK below will forward your account information to a Zacks representative and we will contact you soon to review upgrade options. Close OK. Applied Genetic Technologies Corporation: (AGTC) (Delayed Data AGTC: Applied Genetic Technologies Corporation - Full Company Report. The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style. Applied Genetic Stock Up on Favorable Eye Therapy Study Data Zacks Equity Research - Zacks Investment Research - Fri Jan 10, 9:08AM CST Zacks Equity Research - ZACKS - Fri Jan 10, 9:08AM CST Applied Genetic's (AGTC) gene therapy candidate shows promise in an early-stage study to treat X-linked retinitis pigmentosa, a rare eye disorder. 09/04/2019 · Applied Genetic Technologies (AGTC) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices. 10/01/2020 · Investors in Applied Genetic Technologies Corporation AGTC need to pay close attention to the stock based on moves in the options market lately. That is because the Feb 21, 2020 $7.50 Call had some of the highest implied volatility of all equity options today.What is Implied Vol AGTC: Applied Genetic Technologies Corporation - Interactive Chart Chart. The Zacks Scorecard is a complimentary set of indicators to use alongside the Zacks Rank. It allows the investor to better focus on the stocks that are the best fit for his or her personal investment style.
Applied Genetic Stock Up on Favorable Eye Therapy Study Data Zacks Equity Research - Zacks Investment Research - 1 hour ago Zacks Equity Research - ZACKS - 1 hour ago Applied Genetic's (AGTC) gene therapy candidate shows promise in an early-stage study to treat X-linked retinitis pigmentosa, a rare eye disorder.
5 days ago Investors need to pay close attention to Applied Genetic Technologies (AGTC) stock based on the movements in the options market lately.
Get today's Applied Genetic stock price and latest AGTC news as well as Applied Genetic real-time stock quotes, technical Zacks Investment Research.
06/11/2019 · Applied Genetic Technologies Corp. company facts, information and stock details by MarketWatch. View agtc business summary and other industry information. Applied Genetic Technologies (NASDAQ:AGTC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report issued on Tuesday, Zacks.com reports. According to Zacks, “Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan Implied Volatility Surging for Applied Genetic Technologies (AGTC) Stock Options. January 12, 2017, 08:45:00 AM EDT By Zacks.com. Shutterstock photo. Investors in Applied Genetic Technologies Corporation AGTC need to pay close attention to the stock based on moves in the options market lately. That is because the January 20 th, 13/06/2019 · Investors focused on the Medical space have likely heard of Applied Genetic Technologies (AGTC), but is the stock performing well in comparison to the rest of its sector peers? By taking a look at the stock's year-to-date performance in comparison to its Medical peers, we 03/03/2016 · O ne stock that might be an intriguing choice for investors right now is Applied Genetic Technologies CorporationAGTC. This is because this security in the biotechnology space is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective. Zacks Investment Research upgraded shares of Applied Genetic Technologies (NASDAQ:AGTC) from a sell rating to a hold rating in a research report released on Tuesday, Zacks.com reports. According to Zacks, “Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited orphan Applied Genetic Stock Up on Favorable Eye Therapy Study Data Zacks Equity Research - Zacks Investment Research - 1 hour ago Zacks Equity Research - ZACKS - 1 hour ago Applied Genetic's (AGTC) gene therapy candidate shows promise in an early-stage study to treat X-linked retinitis pigmentosa, a rare eye disorder.
View AGTC's stock price, price target, earnings, financials, forecast, insider trades, According to Zacks Investment Research, "Applied Genetic Technologies
07/05/2015 · Applied Genetic Technologies Corporation ( AGTC) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The upside came after researchers from Michigan State University and the University of Pennsylvania presented … Zacks Investment Research cut shares of Applied Genetic Technologies (NASDAQ:AGTC) from a buy rating to a hold rating in a research report report published on Monday, Zacks.com reports. According to Zacks, “Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops gene therapy products for inherited 11/10/2019 · Applied Genetic Technologies (NASDAQ:AGTC) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a research report issued to clients and investors on Friday, Zacks.com reports. According to Zacks, “Applied Genetic Technologies Corporation is a clinical-stage biotechnology company. It develops Applied Genetic Technologies Corp (NASDAQ:AGTC) – Research analysts at Wedbush decreased their Q2 2020 earnings per share estimates for shares of Applied Genetic Technologies in a report issued on Wednesday, November 13th, Zacks Investment Research reports. Wedbush analyst D. Nierengarten now forecasts that the biotechnology company will post Get today's Applied Genetic stock price and latest AGTC news as well as Applied Genetic real-time stock quotes, technical analysis, full financials and more.
by Zacks Equity Research Published on June 04,2019 . bluebird bio (BLUE) announces that the EC has granted conditional marketing authorization to Zynteglo, its first gene therapy, for patients aged 12 years or older with TDT, who do not have a specific genotype. ANIK AGTC BLUE AXGT. biotechs AGTC: Applied Genetic Technologies Corporation broker recommendation chart. Get the latest chart with broker recommendations from Zacks Investment Research. These returns cover a period from January 1, 1988 through December 2, 2019. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. Implied Volatility Surging for Applied Genetic Technologies (AGTC) Stock Options Zacks Equity Research 2 days ago. Applied Genetic Technologies' stock rockets on early-stage eye therapy data MarketWatch 3 days ago. BRIEF-AGTC Reports Positive Six-Month Data From Its Ongoing